Journal of Ophthalmology / 2014 / Article / Tab 2

Clinical Study

Intravitreal Bevacizumab Alone or Combined with Macular Laser Photocoagulation for Recurrent or Persistent Macular Edema Secondary to Branch Retinal Vein Occlusion

Table 2

Mean best corrected visual acuity and central subfield thickness at different points.

BCVA ( ) valueCST ( m) value

1 month
3 months
6 months <0.05* <0.01

BCVA = best corrected visual acuity; CST = central subfield thickness; = logarithm of the minimal angle of resolution.
Mean BCVA and mean CST assessed by spectral domain optical coherence tomography at baseline, 1 month, 3 months, and 6 months after the initial retreatment.
and , compared with baseline values (just before the second intravitreal bevacizumab treatment).